{
    "clinical_study": {
        "@rank": "127876", 
        "arm_group": {
            "arm_group_label": "Pts with prostate cancer", 
            "description": "This study is planned to determine the kallikrein panel of 200 patients presenting with biochemical recurrence (PSA>0.05ng/ml) after radical prostatectomy prior to any additional therapy."
        }, 
        "biospec_descr": {
            "textblock": "Blood sample"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "The purpose of this study is to investigate if a new blood test looking at PSA and a group\n      of PSA related proteins in a patient's blood can indicate which men after surgery with a\n      rising PSA could benefit from treatment, and/or indicate which men are at higher risk for\n      recurrence before initial treatment is given."
        }, 
        "brief_title": "Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence", 
        "condition": "Prostate Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Prostatic Neoplasms", 
                "Recurrence"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All patients treated with radical prostatectomy that develop a rising serum PSA\n             >0.05ng/ml and have not received any kind of additional therapy.\n\n        Exclusion Criteria:\n\n          -  Previous additional therapy for prostate cancer\n\n          -  No evidence of rising PSA\n\n          -  Patients unwilling to undergo venesection"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "30 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Potential research subjects will be identified by a member of the patient's treatment, the\n        protocol investigator, or research team at Memorial Sloan-Kettering Cancer Center (MSKCC)."
            }
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 21, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02070575", 
            "org_study_id": "14-041"
        }, 
        "intervention": {
            "arm_group_label": "Pts with prostate cancer", 
            "description": "Venous blood will be collected in a 7ml EDTA Vacutainer tube and will be immediately put on ice. Samples will be centrifuged at 1900g (3000-3200 RPM) for 15 Minutes and the serum aliquoted into freezer vials and stored at -80\u00b0C until analysis.", 
            "intervention_name": "blood draw", 
            "intervention_type": "Other"
        }, 
        "intervention_browse": {
            "mesh_term": "Kallikreins"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "PSA", 
            "Human Kallikrein 2", 
            "locally resected prostate cancer", 
            "biochemical recurrence", 
            "14-041"
        ], 
        "lastchanged_date": "February 21, 2014", 
        "link": {
            "description": "Memorial Sloan Kettering Cancer Center", 
            "url": "http://www.mskcc.org/"
        }, 
        "location": {
            "contact": {
                "last_name": "Vincent Laudone, MD", 
                "phone": "646-422-4306"
            }, 
            "contact_backup": {
                "last_name": "James Eastham, MD", 
                "phone": "646-422-4390"
            }, 
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10065"
                }, 
                "name": "Memorial Sloan Kettering Cancer Center"
            }, 
            "investigator": {
                "last_name": "Vincent Laudone, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence", 
        "overall_contact": {
            "last_name": "Vincent Laudone, MD", 
            "phone": "646-422-4306"
        }, 
        "overall_contact_backup": {
            "last_name": "James Eastham, MD", 
            "phone": "646-422-4390"
        }, 
        "overall_official": {
            "affiliation": "Memorial Sloan-Kettering Cancer Center", 
            "last_name": "Vincent Laudone, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "of patients that present with biochemical recurrence after radical prostatectomy.", 
            "measure": "profile of a panel of kallikrein related serine proteases in the blood", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02070575"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Memorial Sloan-Kettering Cancer Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Memorial Sloan-Kettering Cancer Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}